We use essential cookies (authentication, your saved goals/stack) by default. With your permission we’ll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Sms2.0
Sea Moss Research
Mostly mechanism / observational
5 peer-reviewed studies
What the evidence says
Mostly mechanism / observational
Most Sea Moss studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from medium-quality studies published 2012–2024.
Based on 5 studies
Confidence
Low confidence
Active research area
4 studies in the last 5 years
201220182024
1Review2012
In plain English: A clinical review explicitly names excess seaweed consumption as a source of iodine overload that can cause hypo- or hyperthyroidism — the core safety concern with sea moss.
In plain English: Seaweed was the single strongest dietary contributor to iodine exposure and a measurable route of heavy-metal intake — underscoring sea moss's safety, not efficacy, profile.
Ficheux AS et al. · J Trace Elem Med Biol (2023)
Seaweeds were the strongest contributor to dietary iodine, providing up to ~33% of total iodine exposure
Seaweeds also contribute to dietary exposure to lead, cadmium, inorganic arsenic and mercury (lead up to ~3.1% of total dietary exposure)
Supports the heavy-metal and iodine-load cautions for edible seaweed products
In plain English: Isolated carrageenans from a related Chondrus species slowed cancer-cell growth in a dish — an in-vitro result, not evidence that eating sea moss treats anything.
Tiasto VA et al. · Mar Drugs (2022)
Purified carrageenan oligosaccharides from Chondrus armatus showed antiproliferative effects on cultured gastrointestinal cancer cell lines (IC50 ~184-405 μg/mL)
Effect was via cell-cycle arrest and apoptosis induction in cell culture
Used an isolated compound from a related species, not consumable sea moss
In plain English: Carrageenans from red seaweeds (including Chondrus) suppressed viral particles in cell assays — an in-vitro antiviral observation, not a human immune benefit.
Shulgin A et al. · Heliyon (2024)
Sulfated carrageenans, including λ-carrageenan from Chondrus armatus, suppressed HIV-1-based lentiviral transduction in cultured cells at non-toxic concentrations
Antiviral potency varied with polysaccharide structure
Relevant to topical/microbicide research on isolated carrageenan, not oral sea moss for immunity
In plain English: A compositional study characterizing Chondrus crispus nutrient content and in-vitro bioactivity — not a clinical efficacy trial in humans.
Čmiková N et al. · Life (Basel) (2024)
Characterized the nutritional composition and in-vitro antioxidant/bioactive properties of Chondrus crispus alongside two other seaweeds
Documents that sea moss contains minerals and bioactive compounds, supporting the 'it contains nutrients' claim only
Does NOT test any health outcome in humans — purely compositional and in-vitro